Cellular modulation and HIV reactivation in response to serial treatment of latently HIV infected CD4 T cells with histone deacetylase inhibitors (HDACi)

• J. Maxwell,
• A. Nefedov,
• C. Dorfmeier,
• G. Wu,
• Y. Li,
• P. Zuck,
• D. Hazuda,
• A. Webber,
• R. Barnard,
• B. Howell

Affiliations

J. Maxwell

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

A. Nefedov

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

C. Dorfmeier

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

G. Wu

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

Y. Li

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

P. Zuck

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

D. Hazuda

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

A. Webber

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

R. Barnard

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA

B. Howell

MSD Sharp & Dohme GmbH, Kenilworth, NJ, USA